Stimulation therapy for treating obstructive sleep apnea (OSA) based on compound muscle action potential (CMAP)
US12201832B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 25, 2022 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Jun 6, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36078
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A medical system for obstructive sleep apnea (OSA) treatment includes therapy delivery circuitry configured to output one or more electrical stimulation signals to a tongue of a patient; sensing circuitry configured to sense one or more compound muscle action potential (CMAP) signals, wherein the one or more CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; and processing circuitry configured to: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; receive information indicative of the one or more CMAP signals from the sensing circuitry; determine, based on the one or more CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment; and cause the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.